Emerillon Therapeutics

Montréal, Canada

Emerillon Therapeutics

Montréal, Canada
SEARCH FILTERS
Time filter
Source Type

Mogil J.S.,McGill University | Sorge R.E.,McGill University | Lacroix-Fralish M.L.,McGill University | Smith S.B.,McGill University | And 17 more authors.
Nature Neuroscience | Year: 2011

Quantitative trait locus mapping of chemical/inflammatory pain in the mouse identified the Avpr1a gene, which encodes the vasopressin-1A receptor (V1AR), as being responsible for strain-dependent pain sensitivity to formalin and capsaicin. A genetic association study in humans revealed the influence of a single nucleotide polymorphism (rs10877969) in AVPR1A on capsaicin pain levels, but only in male subjects reporting stress at the time of testing. The analgesic efficacy of the vasopressin analog desmopressin revealed a similar interaction between the drug and acute stress, as desmopressin inhibition of capsaicin pain was only observed in nonstressed subjects. Additional experiments in mice confirmed the male-specific interaction of V1AR and stress, leading to the conclusion that vasopressin activates endogenous analgesia mechanisms unless they have already been activated by stress. These findings represent, to the best of our knowledge, the first explicit demonstration of analgesic efficacy depending on the emotional state of the recipient, and illustrate the heuristic power of a bench-to-bedside-to-bench translational strategy. © 2011 Nature America, Inc. All rights reserved.


Lafreniere R.G.,University of Montréal | Cader M.Z.,University of Oxford | Cader M.Z.,John Radcliffe Hospital | Poulin J.-F.,Emerillon Therapeutics | And 16 more authors.
Nature Medicine | Year: 2010

Migraine with aura is a common, debilitating, recurrent headache disorder associated with transient and reversible focal neurological symptoms 1. A role has been suggested for the two-pore domain (K2P) potassium channel, TWIK-related spinal cord potassium channel (TRESK, encoded by KCNK18), in pain pathways and general anaesthesia2. We therefore examined whether TRESK is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. Here we report a frameshift mutation, F139WfsX24, which segregates perfectly with typical migraine with aura in a large pedigree. We also identified prominent TRESK expression in migrainesalient areas such as the trigeminal ganglion. Functional characterization of this mutation demonstrates that it causes a complete loss of TRESK function and that the mutant subunit suppresses wild-type channel function through a dominantnegative effect, thus explaining the dominant penetrance of this allele. These results therefore support a role for TRESK in the pathogenesis of typical migraine with aura and further support the role of this channel as a potential therapeutic target. © 2010 Nature America, Inc. All rights reserved.

Loading Emerillon Therapeutics collaborators
Loading Emerillon Therapeutics collaborators